FDA D.I.S.C.O.: First Biosimilar Approval for the Treatment of Cancer

 
Share
 

Manage episode 200758329 series 1452688
By Discovered by Player FM and our community — copyright is owned by the publisher, not Player FM, and audio streamed directly from their servers.

Oncologists Dr. Sanjeeve Bala and Dr. Abhilasha Nair from FDA’s Oncology Center of Excellence discuss the recent approval of bevacizumab-awwb, a biosimilar to US-licensed Avastin, marketed as MVASI. MVASI is the first biosimilar approved in the US for the treatment of cancer.

Released on December 21, 2017

135 episodes available. A new episode about every 33 days averaging 0 mins duration .